The determinants of poor respiratory health status in adults living with human immunodeficiency virus infection

AIDS Patient Care and STDs

Volumn 28, Issue 5, 2014, Pages 240-247

  Leung, Janice M ^a   Liu, Joseph C ^a   Mtambo, Andy ^b   Ngan, David ^a   Nashta, Negar ^b   Guillemi, Silvia ^b,c   Harris, Marianne ^b,c   Lima, Viviane D ^b   Mattman, Andre ^c   Shaipanich, Tawimas ^d   Raju, Rekha ^b   Hague, Cameron ^b   Leipsic, Jonathon A ^b   Sin, Don D ^a,d   Montaner, Julio S ^b   Man, S F Paul ^a,d  

^a The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; INTERLEUKIN 6; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; VIRUS LOAD; BODY MASS; CANADA; HEALTH STATUS INDICATOR; LUNG; PATHOPHYSIOLOGY; QUESTIONNAIRE; REGRESSION ANALYSIS; SOCIOECONOMICS; SPIROMETRY; STATISTICAL MODEL;

ADULT; ANTI-HIV AGENTS; BODY MASS INDEX; BRITISH COLUMBIA; CD4 LYMPHOCYTE COUNT; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HEALTH STATUS INDICATORS; HIV INFECTIONS; HUMANS; LINEAR MODELS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; QUESTIONNAIRES; REGRESSION ANALYSIS; SMOKING; SOCIOECONOMIC FACTORS; SPIROMETRY; VIRAL LOAD;

EID: 84899802835     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0373     Document Type: Article

References (50)

1. Samji H, Cescon A, Hogg RS, et al. Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013;8:e81355.
2. Kirk JB, Goetz MB. Human immunodeficiency virus in an aging population, a complication of success. J Am Geriatr Soc 2009;57:2129-2138.
3. Sigel K, Wisnivesky J, Gordon K, et al. HIV as an independent risk factor for incident lung cancer. AIDS (London, England) 2012;26:1017-1025.
4. Kirk GD, Merlo C, O'Driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007;45:103-110.
5. Guaraldi G, Zona S, Alexopoulos N, et al. Coronary aging in HIV-infected patients. Clin Infect Dis 2009;49:1756-1762.
6. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004;109:1603-1608.
7. Drummond MB, Kirk GD, Ricketts EP, et al. Cross sectional analysis of respiratory symptoms in an injection drug user cohort: The impact of obstructive lung disease and HIV. BMC Pulm Med 2010;10:27.
8. Crothers K, Butt AA, Gibert CL, et al. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006;130:1326-1333.
9. Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011;183:388-395.
10. Madeddu G, Fois AG, Calia GM, et al. Chronic obstructive pulmonary disease: An emerging comorbidity in HIVinfected patients in the HAART era? Infection 2012;41: 347-353.
11. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Resp Med 1991;85:25-31; discussion 3-7.
12. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 2000;22:1121-1145.
13. Hirani A, Cavallazzi R, Vasu T, et al. Prevalence of obstructive lung disease in HIV population: A cross sectional study. Resp Med 2011;105:1655-1661.
14. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005;26: 153-161.
15. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
16. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
17. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: Correlation with pathologic scoring. AJR Am J Roentgenol 1997;169:977-983.
18. Agusti A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLoS One 2012;7: e37483.
19. Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:1065-1072.
20. Lomas DA, Silverman EK, Edwards LD, et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009;34:95-102.
21. Kim WD, Chi HS, Choe KH, et al. A possible role for CD8 + and non-CD8 + cell granzyme B in early small airway wall remodelling in centrilobular emphysema. Respirology 2013;18:688-696.
22. Koczulla AR, Noeske S, Herr C, et al. Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patients. Resp Med 2012;106:120-126.
23. Knobloch J, Schild K, Jungck D, et al. The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD. Am J Respir Crit Care Med 2011;183:204-214.
24. Brass DM, Hollingsworth JW, McElvania-Tekippe E, Garantziotis S, Hossain I, Schwartz DA. CD14 is an essential mediator of LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol 2007;293:L77-L83.
25. Bewick V, Cheek L, Ball J. Statistics review 10: Further nonparametric methods. Crit Care 2004;8:196-199.
26. Bewick V, Cheek L, Ball J. Statistics review 8: Qualitative data-Tests of association. Crit Care 2004;8:46-53.
27. Lima VD, Bangsberg DR, Harrigan PR, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr 2010;55:460-465.
28. Nishimura K, Mitsuma S, Kobayashi A, et al. COPD and disease-specific health status in a working population. RespirRes 2013;14:61.
29. Berry CE, Drummond MB, Han MK, et al. Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease. Chest 2012;142:704-711.
30. Burgel PR, Escamilla R, Perez T, et al. Impact of comorbidities on COPD-specific health-related quality of life. Resp Med 2013;107:233-241.
31. Grover KW, Gonzalez A, Zvolensky MJ. HIV symptom distress and smoking outcome expectancies among HIV + smokers: A pilot test. AIDS Patient Care STDS 2013;27: 17-21.
32. Ferrer M, Villasante C, Alonso J, et al. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J 2002;19:405-413.
33. Ataie-Kachoie P, Pourgholami MH, Morris DL. Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer. Cytokine Growth Factor Rev 2013;24:163-173.
34. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008;5:e203.
35. Armah KA, McGinnis K, Baker J, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis 2012;55:126-136.
36. Erlandson KM, Allshouse AA, Jankowski CM, et al. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 2013;208:249-259.
37. Ruwanpura SM, McLeod L, Miller A, et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Respir Cell Mol Biol 2011;45:720-730.
38. Yanbaeva DG, Dentener MA, Spruit MA, et al. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: A case-control study. BMC Med Genet 2009;10:23.
39. Cordoba-Lanus E, de-Torres JP, Lopez-Aguilar C, et al. Association of IL-6 gene polymorphisms and COPD in a Spanish population. Resp Med 2008;102:1805-1811.
40. Holloway RA, Donnelly LE. Immunopathogenesis of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2013;19:95-102.
41. Jones PW, Brusselle G, Dal Negro RW, et al. Healthrelated quality of life in patients by COPD severity within primary care in Europe. Resp Med 2011;105:57-66.
42. Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Vercoulen JH, Heijdra YF. Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1. Resp Med 2013;107:834-840.
43. Farkhooy A, Janson C, Arnardottir RH, Malinovschi A, Emtner M, Hedenstrom H. Impaired carbon monoxide diffusing capacity is the strongest predictor of exercise intolerance in COPD. COPD 2013;10:180-185.
44. Crothers K, McGinnis K, Kleerup E, et al. HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr 2013;64:271-278.
45. Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respir Res 2006;7:52.
46. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: Results from a Danish longitudinal population study. Eur Respir J 997;10:822-827.
47. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005;128: 739-745.
48. Swigris JJ, Brown KK, Behr J, et al. The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF. Resp Med 2010;104:296-304.
49. Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology (Oxford) 2007;46:296-301.
50. Shirley DK, Kesari RK, Glesby MJ. Factors associated with smoking in HIV-infected patients and potential barriers to cessation. AIDS Patient Care STDS 2013;27: 604-612.